Internal Medicine, Endocrinology, Diabetes, & Metabolism · Provo, UT
NPI
1326203514
Since 2008
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1055 N 500 W Ste 205
Provo, UT, 84604
Phone (801) 429-8095
Groups this clinician bills Medicare through
Medicare paid, 2024
$142K
5,270 services
Medicare patients, 2024
498
Average age 74
Drug cost, 2024
$323K
3,033 prescriptions
Company payments, 2025
$2,554
From 28 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mohammed S Nizam was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 762 times for 436 patients. In total Mohammed S Nizam billed 5,270 services in 51 codes, and Medicare paid $142K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-11-27.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 762 | 436 | $11.40 | $8,684 |
| 36415 Venipuncture Blood Collection | Office | 665 | 367 | $8.59 | $5,713 |
| 99214 Office E&M - Established | Office | 653 | 399 | $80.35 | $52K |
| 84443 Clinical Chemistry | Office | 496 | 316 | $16.26 | $8,064 |
| 84439 Clinical Chemistry | Office | 439 | 274 | $8.72 | $3,827 |
| 82306 Clinical Chemistry | Office | 369 | 271 | $28.81 | $11K |
| 80069 Clinical Chemistry | Office | 239 | 138 | $8.48 | $2,027 |
| 83970 Clinical Chemistry | Office | 191 | 126 | $40.45 | $7,726 |
| 80053 Clinical Chemistry | Office | 175 | 131 | $10.19 | $1,783 |
| 76536 Ultrasound - Nonspecific | Office | 128 | 127 | $72.61 | $9,295 |
| 84480 Clinical Chemistry | Office | 110 | 67 | $13.90 | $1,529 |
| 83735 Clinical Chemistry | Office | 89 | 72 | $6.57 | $585 |
| 99204 Office E&M - New | Office | 81 | 81 | $108.00 | $8,748 |
| 96127 Behavioral Health Services | Office | 78 | 78 | $2.85 | $222 |
| 96372 Injection Administration | Office | 72 | 15 | $10.14 | $730 |
By year: 2022 $159K for 6,004 services; 2023 $132K for 8,190 services; 2024 $142K for 5,270 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 665 | 367 | $8.59 | $5,713 |
| 84443 Clinical Chemistry | 496 | 316 | $16.26 | $8,064 |
| 84439 Clinical Chemistry | 439 | 274 | $8.72 | $3,827 |
| 82306 Clinical Chemistry | 369 | 271 | $28.81 | $11K |
| 80069 Clinical Chemistry | 239 | 138 | $8.48 | $2,027 |
| 83970 Clinical Chemistry | 191 | 126 | $40.45 | $7,726 |
| 80053 Clinical Chemistry | 175 | 131 | $10.19 | $1,783 |
| 84480 Clinical Chemistry | 110 | 67 | $13.90 | $1,529 |
| 83735 Clinical Chemistry | 89 | 72 | $6.57 | $585 |
| 82570 Clinical Chemistry | 71 | 65 | $5.01 | $356 |
Medicare prescription drug claims, 2024
In 2024, the drug Mohammed S Nizam prescribed most often to Medicare patients was Levothyroxine Sodium, with 1,146 prescriptions and refills. In total Mohammed S Nizam wrote 3,033 Medicare prescriptions that cost $323K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 1,146 | 3,051 | 312 | $14K |
| Methimazole Generic | 308 | 776 | 81 | $4,854 |
| Calcitriol Generic | 210 | 560 | 70 | $6,740 |
| Synthroid Levothyroxine Sodium | 184 | 502 | 54 | $17K |
| Hydrocortisone Generic | 164 | 361 | 42 | $8,562 |
| Alendronate Sodium Generic | 161 | 424 | 49 | $1,309 |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 70 | 201 | 28 | $864 |
| Liothyronine Sodium Generic | 68 | 187 | 17 | $3,506 |
| Cinacalcet Hcl Generic | 42 | 92 | 11 | $3,423 |
| Fludrocortisone Acetate Generic | 42 | 100 | Under 11 | $1,202 |
| Testosterone Generic | 39 | 77 | 11 | $5,587 |
| Testosterone Cypionate Generic | 32 | 66 | Under 11 | $1,140 |
| Lisinopril Generic | 26 | 51 | Under 11 | $234 |
| Hydrochlorothiazide Generic | 25 | 77 | Under 11 | $252 |
| Jardiance Empagliflozin | 24 | 63 | Under 11 | $38K |
Brand drugs: 715 claims; generic drugs: 2,288 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mohammed S Nizam $2,554 ($2,554 in general payments such as food, travel and fees) from 28 companies. The largest payer was Abbott Laboratories with $368.
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories ABT | 8 | $368 |
| Ascendis Pharma Endocrinology Inc ASND | 18 | $236 |
| Amgen Inc. AMGN | 12 | $181 |
| Tandem Diabetes Care, Inc. TNDM | 8 | $175 |
| Sanofi-Aventis U.S. LLC SNY | 7 | $171 |
| Radius Health, Inc. | 16 | $151 |
| Medtronic, Inc. MDT | 10 | $148 |
| Beta Bionics, Inc. BBNX | 7 | $141 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 6 | $118 |
| Neurocrine BioSciences, Inc. NBIX | 3 | $109 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.